The group’s different lines of research focus on greater understanding of the pathogenic mechanisms behind multiple sclerosis, with the aim of developing new, more effective therapeutic measures. In order to cover the majority of aspects related to the illness, with the ultimate aim of improving patients’ quality of life, the research group’s interests also centre around developing therapeutic tools in multiple sclerosis, getting to know susceptibility of the disease and identifying diagnostic and prognostic markers. In direct relation with patients, the group studies the responses to treatment in patients with multiple sclerosis, conducts clinical and radiological studies on patients with the disease, and works to understand the epidemiology of multiple sclerosis.

Visit the research group’s page